Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: A randomized study
- 1 January 2006
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (1) , 303-307
Abstract
Background: Therapeutic paracentesis in patients with cirrhosis induces arterial vasodilatation, causes a decrease in effective arterial blood volume and leads to circulatory dysfunction, which can be prevented by intravenous albumin. However, the use of albumin, being a blood product, is controversial. Recently, terlipressin, a vasoconstrictor, has been successfully used to combat this adverse effect of therapeutic paracentesis. Therefore, the aim of the present study was to investigate the preventive effect of terlipressin on paracentesis‐induced circulatory dysfunction in patients with cirrhosis after therapeutic paracentesis and compared with that of intravenous albumin.Methods: Forty patients with cirrhosis and tense ascites underwent therapeutic paracentesis with albumin or terlipressin in a randomized pilot study at a tertiary center. Effective arterial blood volume was assessed by measuring plasma renin activity at baseline and at 4–6 days after treatment.Results: Effective arterial blood volumes as indicated by plasma renin activity before and 4–6 days after paracentesis did not differ in the two groups (19.15 ± 12.1 to 20.33 ± 12.8 ng/mL per h, P = 0.46 in the albumin group; and 20.11 ± 10.6 to 21.08 ± 10.52 ng/mL per h, P = 0.44 in the terlipressin group). Plasma aldosterone concentrations before and 4–6 days after paracentesis were also similar in both groups (1334.75 ± 1058 to 1440.0 ± 1161 pg/mL, P = 0.06 in the albumin group; and 1473.0 ± 1168 to 1572.29 ± 1182 pg/mL, P = 0.24 in the terlipressin group). Both terlipressin and albumin prevented paracentesis‐induced renal impairment in these patients.Conclusions: Terlipressin may be as effective as intravenous albumin in preventing paracentesis‐induced circulatory dysfunction in patients with cirrhosis after therapeutic paracentesis.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot studyGut, 2002
- Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansionHepatology, 1998
- Management of adult patients with ascites caused by cirrhosis†Hepatology, 1998
- Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesisHepatology, 1995
- Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascitesGastroenterology, 1994
- Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trialLiver International, 1993
- Single, Total Paracentesis for Tense Ascites: Sequential Hemodynamic Changes and Right Atrial SizeHepatology, 1990
- Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosisGastroenterology, 1988
- Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal functionHepatology, 1987
- PARACENTESIS VERSUS DIURETICS IN THE TREATMENT OF CIRRHOTICS WITH TENSE ASCITESThe Lancet, 1985